COMPARISON OF POST OPERATIVE ANALGESIC EFFECT OF DEXMEDETOMIDINE AND CLONIDINE WHEN USED AS ADJUVANT TO ROPIVACAINE BY CAUDAL EPIDURAL ROUTE IN CHILDRE
Phase 3
Not yet recruiting
- Conditions
- Health Condition 1: N00-N99- Diseases of the genitourinary system
- Registration Number
- CTRI/2018/12/016669
- Lead Sponsor
- IGIMS PATNA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA GRADE 1 AND 2
AGE BETWEEN 3 YEARS TO 8 YEARS
PATIENT COMING FOR INFRA UMBILICAL SURGERIES
Exclusion Criteria
ASA GRADE 3 AND 4
PATIENT NOT WILLING FOR THE PROCEDURE
INFECTION AT THE SITE OF INJECTION
COAGULOPATHY OR ANTICOAGULATIO
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method DURATION OF ANAESTHESIA <br/ ><br>TIME FOR CAUDAL BLOCK TO SKIN INCISION <br/ ><br>TIME FOR CAUDAL BLOCK TO END OF SURGERY <br/ ><br>EMERGENCE TIME <br/ ><br>Timepoint: DURATION OF ANAESTHESIA <br/ ><br>TIME FOR CAUDAL BLOCK TO SKIN INCISION <br/ ><br>TIME FOR CAUDAL BLOCK TO END OF SURGERY <br/ ><br>EMERGENCE TIME <br/ ><br>
- Secondary Outcome Measures
Name Time Method ADVERSE EFFECTSTimepoint: 0 to 2 hours <br/ ><br>2 to 24 hours
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie alpha-2 adrenergic receptor agonists in enhancing ropivacaine analgesia via caudal epidural in pediatric genitourinary surgeries?
How does CTRI/2018/12/016669 compare the analgesic efficacy of dexmedetomidine and clonidine as adjuvants to ropivacaine in pediatric post-operative pain management?
Which pharmacogenetic biomarkers predict differential response to dexmedetomidine or clonidine in pediatric caudal epidural analgesia for genitourinary procedures?
What are the safety profiles and management strategies for hypotension or sedation caused by alpha-2 agonist adjuvants in CTRI/2018/12/016669 pediatric phase III trial?
How do combination approaches of alpha-2 agonists with fentanyl or bupivacaine compare to ropivacaine-based caudal epidural analgesia in pediatric urological surgeries?